This HTML5 document contains 144 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.3349/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q35971059
rdf:type
wikibase:Item
schema:description
vedecký článok научная статья vitskapeleg artikkel artigo científico 2015年論文 tieteellinen artikkeli 2015年論文 artigo científico (publicado na 2015) 2015年论文 מאמר מדעי naučni članak artículo científico publicado en 2015 artículu científicu espublizáu en 2015 научни чланак article scientific επιστημονικό άρθρο wetenschappelijk artikel mokslinis straipsnis article científic bài báo khoa học 2015 nî lūn-bûn 2015年论文 научна статия 2015年論文 wissenschaftlicher Artikel 2015年論文 2015年论文 bilimsel makale artigo científico (publicado na 2015) artikulong pang-agham videnskabelig artikel (udgivet 2015) 2015年论文 บทความทางวิทยาศาสตร์ teaduslik artikkel vetenskaplig artikel articolo scientifico article scientifique (publié 2015) 2015年の論文 2015년 논문 мақолаи илмӣ سائنسی مضمون ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2015年論文 tudományos cikk scienca artikolo vědecký článek مقالهٔ علمی 2015年论文 научни чланак vitenskapelig artikkel мақолаи илмӣ სამეცნიერო სტატია artikull shkencor 2015年论文 artykuł naukowy գիտական հոդված scientific article наукова стаття, опублікована у вересні 2015 مقالة علمية articol științific
p:P577
wds:Q35971059-07D88B7C-8C9C-4540-9EAB-8E8F4C695E3B
wdt:P577
2015-09-01T00:00:00Z
p:P2860
wds:Q35971059-09C36D00-EBAE-47A1-9E6E-911D41EB5F22 wds:Q35971059-7A0FFEBC-96C4-4BC8-B397-103B34EA9713 wds:Q35971059-8377561D-5BFD-4110-8B99-332DE4214E1F wds:Q35971059-B228BCF7-1CC9-4643-B389-844CCC4E3D1E wds:Q35971059-B3615698-825D-4B68-8086-A70F33A0969D wds:Q35971059-C6A7033B-203F-4A6E-B5B0-93B68E151D5C wds:Q35971059-DDED70D7-8C63-4465-AAD5-362A881C0FD8 wds:Q35971059-DFD6221B-B536-4FE9-86F3-6D75145D173E wds:Q35971059-E1512CD2-E1AF-43EE-919C-20B33260A5E6 wds:Q35971059-E4A5DCC0-EAA2-41FD-8D17-1181FFCD05A9 wds:Q35971059-F192B3A8-2058-46A9-9396-57B85F47C247 wds:Q35971059-41C660E1-994F-427D-A83D-1A3BFDCAF32D wds:Q35971059-4C118224-FF5F-46BF-92E0-C075D62118C2 wds:Q35971059-5150C2B5-39E9-4C89-B218-B00511C750DC wds:Q35971059-590F7CC9-D6ED-4E47-89FA-ED177A04720F wds:Q35971059-60001832-5CA1-4597-AF7B-D4B0D15BC77E wds:Q35971059-62E8341D-C163-49AE-98A4-2BCE8EBA3BFD wds:Q35971059-65A835CC-DAA3-4AB7-AE01-DEEFF0005B15 wds:Q35971059-6845F862-3B37-4F67-A719-BE8D527F194F wds:Q35971059-6F6FF898-5BE3-4CBE-ABA2-B974E61CF886
wdt:P2860
wd:Q40946164 wd:Q42286867 wd:Q54559748 wd:Q38114421 wd:Q34722269 wd:Q59617507 wd:Q44491002 wd:Q44781129 wd:Q57991151 wd:Q42243021 wd:Q40617694 wd:Q28304595 wd:Q35648288 wd:Q46621049 wd:Q34403117 wd:Q35928948 wd:Q36139832 wd:Q53648370 wd:Q69588607 wd:Q43890461
p:P2093
wds:Q35971059-2B0177F2-90E1-41BC-88B9-93EA8EDEF1E4 wds:Q35971059-26496BD3-B2DC-4C5C-B14A-F536F17C422A wds:Q35971059-A3F425A7-A708-409E-AEB7-28BB15875EFE
wdt:P2093
Seong-Heon Wie Hyung Wook Kim U-Im Chang
rdfs:label
Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis
skos:prefLabel
Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis
schema:name
Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis
p:P1476
wds:Q35971059-242FD293-F23B-4FB3-ADF6-880F3FF5405B
wdt:P1476
Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis
p:P304
wds:Q35971059-F563C7CB-1DAF-4F04-98AE-BBEBEEA72B43
wdt:P304
1266-1273
p:P31
wds:Q35971059-457E4A61-6219-4CE4-94E2-95023D79EF42
wdt:P31
wd:Q13442814
p:P698
wds:Q35971059-DF4E073B-EC68-416D-B637-B42F74476761
wdtn:P698
n9:26256969
wdt:P698
26256969
p:P1433
wds:Q35971059-5C19760E-F191-414E-B3D9-F32C4BCD1C53
wdt:P1433
wd:Q8055114
p:P433
wds:Q35971059-E18A5DC3-9C34-457A-884C-38C24FDB99D8
p:P478
wds:Q35971059-707BE71D-77D2-49F5-A087-F062B5C2F11D
wdt:P433
5
wdt:P478
56
p:P356
wds:Q35971059-8378D75B-36D5-40E2-B110-FABB790895E9
wdtn:P356
n11:YMJ.2015.56.5.1266
wdt:P356
10.3349/YMJ.2015.56.5.1266
p:P275
wds:Q35971059-b9674d40-68d7-454a-b5e4-af7ec7dc3b61
p:P6216
wds:Q35971059-5d59e551-f62f-498d-9aa7-cbebed31c712
wdt:P275
wd:Q18810331
wdt:P6216
wd:Q50423863
p:P5875
wds:Q35971059-7B484BDE-99A8-4AF6-AF26-0D68BC752279
wdt:P5875
280968611
p:P932
wds:Q35971059-F0EC17C2-F381-4D89-BAC6-F1F26251AA40
wdt:P932
4541656